Institute of Biomaterial Science, Helmholtz-Zentrum Geesthacht, Kantstr. 55, 14513, Teltow, Germany.
Berlin-Brandenburg Center for Regenerative Therapies (BCRT), 13353, Berlin, Germany.
J Mol Med (Berl). 2020 Dec;98(12):1767-1779. doi: 10.1007/s00109-020-01956-1. Epub 2020 Nov 4.
Advanced non-viral gene delivery experiments often require co-delivery of multiple nucleic acids. Therefore, the availability of reliable and robust co-transfection methods and defined selection criteria for their use in, e.g., expression of multimeric proteins or mixed RNA/DNA delivery is of utmost importance. Here, we investigated different co- and successive transfection approaches, with particular focus on in vitro transcribed messenger RNA (IVT-mRNA). Expression levels and patterns of two fluorescent protein reporters were determined, using different IVT-mRNA doses, carriers, and cell types. Quantitative parameters determining the efficiency of co-delivery were analyzed for IVT-mRNAs premixed before nanocarrier formation (integrated co-transfection) and when simultaneously transfecting cells with separately formed nanocarriers (parallel co-transfection), which resulted in a much higher level of expression heterogeneity for the two reporters. Successive delivery of mRNA revealed a lower transfection efficiency in the second transfection round. All these differences proved to be more pronounced for low mRNA doses. Concurrent delivery of siRNA with mRNA also indicated the highest co-transfection efficiency for integrated method. However, the maximum efficacy was shown for successive delivery, due to the kinetically different peak output for the two discretely operating entities. Our findings provide guidance for selection of the co-delivery method best suited to accommodate experimental requirements, highlighting in particular the nucleic acid dose-response dependence on co-delivery on the single-cell level.
高级非病毒基因传递实验通常需要同时传递多种核酸。因此,可靠和稳健的共转染方法的可用性以及其在例如多聚体蛋白表达或混合 RNA/DNA 传递中的使用的明确选择标准是至关重要的。在这里,我们研究了不同的共转染和连续转染方法,特别关注体外转录的信使 RNA(IVT-mRNA)。使用不同的 IVT-mRNA 剂量、载体和细胞类型,确定了两种荧光蛋白报告基因的表达水平和模式。对于在纳米载体形成之前预先混合的 IVT-mRNA(集成共转染)和同时用分别形成的纳米载体转染细胞(平行共转染)分析了决定共传递效率的定量参数,这导致两个报告基因的表达异质性水平大大提高。mRNA 的连续传递在第二轮转染中显示出较低的转染效率。所有这些差异对于低剂量的 mRNA 更为明显。与 mRNA 同时递送 siRNA 也表明集成方法的共转染效率最高。然而,由于两个离散操作实体的动力学不同,连续传递显示出最大的功效。我们的研究结果为选择最适合满足实验要求的共传递方法提供了指导,特别是强调了在单细胞水平上共传递对核酸剂量反应的依赖性。